LONG-TERM DISEASE OUTCOMES IN SYMPTOMATIC MULTIPLE MYELOMA PATIENTS: A RETROSPECTIVE ANALYSIS OF THE PHAROS REGISTRY

被引：2
|
作者：
Verelst, S. G. [1 ]
Blommestein, H. M. [2 ,3 ,4 ]
De Groot, S. [2 ,4 ]
Gonzalez-McQuire, S. [5 ]
DeCosta, L. [6 ]
de Raad, J. [7 ,8 ]
Sonneveld, P. [1 ]
Uyl-de Groot, C. A. [9 ]
机构：
[1] Erasmus Univ, Med Ctr, Rotterdam, Netherlands
[2] Erasmus Univ, Inst Hlth Policy & Management, Rotterdam, Netherlands
[3] Comprehens Canc Org, Utrecht, Netherlands
[4] Erasmus Univ, Inst Med Technol Assessment, Rotterdam, Netherlands
[5] Amgen Europe GmbH, Zug, Switzerland
[6] Amgen Ltd, Uxbridge, Middx, England
[7] Amgen BV, Breda, Netherlands
[8] Univ Utrecht, Breda, Netherlands
[9] Erasmus Univ, Rotterdam, Netherlands
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 03期
关键词：
D O I：
10.1016/j.jval.2016.03.1537
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN204
引用
收藏
页码：A170 / A170
页数：1
相关论文
共 50 条
  • [11] Impact of Hematologic Parameters in Newly Diagnosed Multiple Myeloma Patients on Long-Term Outcomes
    Joseph, Nisha
    Nooka, Ajay
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S257 - S257
  • [12] Long-term outcomes of children with symptomatic congenital cytomegalovirus disease
    Lanzieri, T. M.
    Leung, J.
    Caviness, A. C.
    Chung, W.
    Flores, M.
    Blum, P.
    Bialek, S. R.
    Miller, J. A.
    Vinson, S. S.
    Turcich, M. R.
    Voigt, R. G.
    Demmler-Harrison, G.
    JOURNAL OF PERINATOLOGY, 2017, 37 (07) : 875 - 880
  • [13] Long-term outcomes of children with symptomatic congenital cytomegalovirus disease
    T M Lanzieri
    J Leung
    A C Caviness
    W Chung
    M Flores
    P Blum
    S R Bialek
    J A Miller
    S S Vinson
    M R Turcich
    R G Voigt
    G Demmler-Harrison
    Journal of Perinatology, 2017, 37 : 875 - 880
  • [14] Bortezomib and dexamethasone as salvage therapy in patients with relapsed/refractory multiple myeloma: analysis of long-term clinical outcomes
    Lucia Pantani
    Elena Zamagni
    Beatrice Anna Zannetti
    Annalisa Pezzi
    Paola Tacchetti
    Annamaria Brioli
    Katia Mancuso
    Giulia Perrone
    Serena Rocchi
    Patrizia Tosi
    Michele Cavo
    Annals of Hematology, 2014, 93 : 123 - 128
  • [15] Bortezomib and dexamethasone as salvage therapy in patients with relapsed/refractory multiple myeloma: analysis of long-term clinical outcomes
    Pantani, Lucia
    Zamagni, Elena
    Zannetti, Beatrice Anna
    Pezzi, Annalisa
    Tacchetti, Paola
    Brioli, Annamaria
    Mancuso, Katia
    Perrone, Giulia
    Rocchi, Serena
    Tosi, Patrizia
    Cavo, Michele
    ANNALS OF HEMATOLOGY, 2014, 93 (01) : 123 - 128
  • [16] THALIDOMIDE AND DEXAMETHASONE AS SALVAGE THERAPY AT FIRST RELAPSE IN PATIENTS WITH MULTIPLE MYELOMA: ANALYSIS OF LONG-TERM CLINICAL OUTCOMES
    Zamagni, E.
    Petrucci, A.
    Tosi, P.
    Tacchetti, P.
    Brioli, A.
    Pantani, L.
    Perrone, G.
    Baccarani, M.
    Cavo, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 154 - 154
  • [17] Long-term outcomes in patients with multiple sclerosis
    Bates, David
    NEUROLOGY, 2011, 76 (01) : S1 - S2
  • [18] LONG-TERM SYMPTOMATIC OUTCOMES AMONG PATIENTS WITH JACKHAMMER ESOPHAGUS
    Carlson, Dustin
    Starkey, Kristen
    Listernick, Zoe
    Rinella, Nicolas
    Pandolfino, John E.
    GASTROENTEROLOGY, 2017, 152 (05) : S319 - S320
  • [19] The long-term outcomes of symptomatic congenital lobar emphysema patients
    Gatt, Dvir
    Lapidus-Krol, Eveline
    Chiu, Priscilla P. L.
    PEDIATRIC PULMONOLOGY, 2023, 58 (05) : 1520 - 1526
  • [20] Multiple myeloma: optimal management and long-term disease control
    Sriskandarajah, Priya
    Davies, Faith E.
    BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY, 2014, 4 : 121 - 134
12345